HUM Trading Analysis - 10/08/2026 11:24 AM — TRU-SENTIMENT

News Headlines & Context

The following items are provided from general knowledge and are separate from the data-driven analysis below:

• Humana (HUM) faces ongoing Medicare Advantage regulatory scrutiny, with CMS proposing stricter payment adjustments that could pressure 2027 margins.
• Industry reports indicate rising medical loss ratios across managed-care names, raising investor concern about sector profitability.
• HUM declared a quarterly dividend with ex-dividend date of 2026-10-30 (per fundamentals), a near-term shareholder event.
• Managed-care stocks have been volatile amid enrollment growth uncertainty and policy headline risk.
• Broader healthcare sector rotation has pressured high-beta names (HUM beta 1.38) more than defensives.

Context: Headline policy and sector stress align with the embedded bearish options sentiment, even as daily technicals show only mild upward bias.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

• Trailing P/E: 37.20; Trailing EPS: $10.66; Market Cap: $45.62B; Shares Out: 120.08M.
• Dividend Yield: 0.89% (Rate $3.54); Ex-Dividend: 2026-10-30; Institutional Ownership: 73.71%.
• Beta: 1.38 (elevated relative to market); 52-Week Range: $163.11 to $428.88.
• Historical Volatility: 29.91%; Average Volume: 1.19M; Fiscal Year End: 2025-12-01.
• PEG Ratio, Forward P/E, Forward EPS, Profit Margins, ROE, Debt/Equity, Free Cash Flow, Revenue Growth, Total Revenue: all null (not provided).
• Analyst consensus, target mean price, and number of opinions: null (not provided).

Fundamental strengths: solid institutional base and positive EPS. Concerns: rich trailing P/E of 37.20 with no PEG or margin data to justify valuation; elevated beta increases drawdown risk. Fundamentals neither confirm nor break the technical picture, but high valuation plus missing growth data leaves fundamental support unverified.

Current Market Position

Per embedded data: Daily close on 2026-10-07 was $397.16, with intraday minute bars showing a drop from $407.35 (2026-10-07 09:30) to $381.07 (2026-10-08 10:55). Last 5 minute bars illustrate steady intraday decline (high $385.42 to low $381.07) on thinning volume (47,464 to 14,432).

Daily range on 2026-10-07: $396.00 low to $410.01 high. 30-day range: $369.13 to $419.97. Price sits in upper-middle of 30-day range but below recent 2026-10-06 close of $404.43.

Technical Analysis

SMA alignment: 5 > 20 > 50 ($394.44 > $390.39 > $386.35) indicates mild bullish stacking with no bearish crossover. RSI 56.52 shows neutral-to-modestly bullish momentum, not overbought. MACD (1.40) above signal (1.12) with positive histogram (0.28) confirms weak bullish bias. Bollinger Bands: middle $390.39, upper $412.13, lower $368.65; price $397.16 is above middle and within bands (no squeeze indicated). 30-day high $419.97, low $369.13; current price is ~63% up the range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow via True Sentiment (Delta 40-60 only):

Call Volume: $562,610.00 (17.70%) Put Volume: $2,609,040.00 (82.30%) Total: $3,171,650.00

Sentiment: Bearish. Contracts: 229 calls vs 891 puts; trades balanced at 26 each, but put dollar conviction dominates. Pure directional positioning suggests near-term downside expectations. Divergence: technicals show mild bullish stack while options signal bearish — confirmed by spread engine: "Divergence detected between technical indicators and options sentiment."

Key Price Levels (Observational Only)